Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda
暂无分享,去创建一个
Ronald H Gray | Stephen J Gange | Richard D Moore | Tom Lutalo | N. Sewankambo | S. Gange | T. Quinn | R. Gray | M. Wawer | D. Serwadda | Xianbin Li | T. Lutalo | F. Wabwire-mangen | David Serwadda | Nelson K Sewankambo | Fred Wabwire-Mangen | Thomas C Quinn | Maria J Wawer | Xianbin Li | Richard Moore | Richard D. Moore | R. Gray
[1] Steven Gibson,et al. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. , 2002, American journal of public health.
[2] H. Binswanger. Public health. HIV/AIDS treatment for millions. , 2001, Science.
[3] John W. Mellors,et al. Panel on Clinical Practices for Treatment of HIV Infection , 2000 .
[4] M C Weinstein,et al. The cost effectiveness of combination antiretroviral therapy for HIV disease. , 2001, The New England journal of medicine.
[5] Debashis Kushary,et al. Bootstrap Methods and Their Application , 2000, Technometrics.
[6] H. P. Binswanger. HIV/AIDS Treatment for Millions , 2001, Science.
[7] Maureen Miller,et al. Sexual behavior changes and protease inhibitor therapy , 2000 .
[8] R. Anderson,et al. Low-efficacy HIV vaccines: potential for community-based intervention programmes , 1996, The Lancet.
[9] S. Long,et al. Access to treatment for HIV in developing countries; statement from international seminar on access to treatment for HIV in developing countries, London, June 5 and 6, 1998 , 1998, The Lancet.
[10] C. Yoder,et al. Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression , 2000, AIDS.
[11] H. Gershengorn,et al. A tale of two futures: HIV and antiretroviral therapy in San Francisco. , 2000, Science.
[12] N. Michael,et al. Joint United Nations Programme on HIV/AIDS. , 2004, Military medicine.
[13] G. Garnett,et al. An introduction to mathematical models in sexually transmitted disease epidemiology , 2002, Sexually transmitted infections.
[14] W. Spaan,et al. Access to treatment for HIV in developing countries , 1999, The Lancet.
[15] J. Esparza,et al. Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how? , 2000, The Lancet.
[16] R. Selik,et al. Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984-1997. , 2001, JAMA.
[17] R. Hogg,et al. Models of survival in HIV infection and their use in the quantification of treatment benefits. , 1998, American journal of epidemiology.
[18] S. Holmberg,et al. Changes in HIV and AIDS epidemiology from new generation antiretroviral therapy. , 1999, AIDS.
[19] Ronald H Gray,et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial , 1999, The Lancet.
[20] Joseph Feldman,et al. The Women's Interagency HIV Study , 1998 .
[21] R. Moore,et al. Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[22] Noah Kiwanuka,et al. Mortality associated with HIV infection in rural Rakai District, Uganda , 2000, AIDS.
[23] HOMAS,et al. VIRAL LOAD AND HETEROSEXUAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 VIRAL LOAD AND HETEROSEXUAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 , 2000 .
[24] D. Cooper,et al. Adverse effects of antiretroviral therapy , 2000, The Lancet.
[25] Arriaga Ee,et al. Population analysis with microcomputers. , 1994 .
[26] S. Kippax,et al. Modelling the effect of combination antiretroviral treatments on HIV incidence , 2001, AIDS.
[27] Thomas C. Quinn,et al. A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda , 1998, AIDS.
[28] Providing antiretroviral therapy for HIV infection. , 2001, The New England journal of medicine.
[29] Anthony C. Davison,et al. Bootstrap Methods and Their Application , 1998 .
[30] C. Mahé,et al. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? , 2002, AIDS.
[31] J. Gallant,et al. Strategies for long-term success in the treatment of HIV infection. , 2000, JAMA.
[32] D. McCaffrey,et al. Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. , 2001, The New England journal of medicine.